BNET Industries
Last Fiscal Year Sales:$48.2M
- Private
- US
Dow Jones Description
Amphastar Pharmaceuticals, Inc., established in 1996, is a specialty and generic pharmaceutical company focusing on injectable, inhalation, and other categories of pharmaceutical products. Amphastar's state-of-the-art, aseptic, cGMP compliant facilities develop, manufacture, and market innovative proprietary and generic products using new technologies and delivery systems. Amphastar is staffed with highly dedicated and experienced professionals who are committed to providing quality products at competitive prices.
President & CEO
Jack Y. ZhangNumber of Employees 729
Contact Information
11570 6th St
Rancho Cucamonga, California 91730
(909) 980-9484
Peer Companies
NAICS Code Other Commercial and Service Industry Machinery Manufacturing: 333319
Recent Events
-
FDA Drug Chief Accused of Conflict
News & Analysis
Filter by
amphastar pharmaceuticals inc. - All News and Analysis
GE Healthcare Financial Services Closes $20 Million Financing Deal with Amphastar Pharmaceuticals, Inc
CHICAGO -- GE Healthcare Financial Services has provided a $20 million senior term loan to Amphastar Pharmaceuticals, Inc., a generic and specialty pharmaceutical company based in Rancho Cucamonga, Calif., that focuses on injectable and inhalation products.
Stradling Lawyer Wins for Generics; Appeal Pending
Doctors' Blood Boils Over CalOptima HMO; Blue Shield Honors Hospitals for Cardiac Care HEALTHCARE A patent fight led by an Orange County law firm could add up to a windfall for a generic drug maker. U.S. District Judge Robert Timlin last month granted a summary judgment in favor...
Andrx Enters into Alliance for Generic Lovenox with Amphastar
FORT LAUDERDALE, Fla. -- Andrx Corporation (Nasdaq:ADRX) ("Andrx" or the "Company") announced today that it has entered into an agreement to obtain certain exclusive marketing rights for both strengths of Amphastar Pharmaceuticals, Inc.'s ("Amphastar") proposed generic version of LovenoxR, Aventis Pharmaceuticals, Inc.'s ("Aventis") enoxaparin sodium injectable product. Amphastar submitted its...
IPO to be a shot in arm for drug firm.
By Darla Martin Tucker, The Business Press, San Bernardino, Calif. Knight Ridder/Tribune Business News Feb. 21--A Rancho Cucamonga drug maker that employs 730 people has filed an initial public offering with the U.S. Securities and Exchange Commission to raise...
- 1
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Jack Y. Zhang | President & CEO |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Mary Z. Luo | Chairman & COO |
| Richard Prins | Board of Directors |
| Organization | Position | Status |
|---|---|---|
| Amphastar Pharmaceuticals, Inc. | President & CEO | Current |
| Amphastar Pharmaceuticals, Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Amphastar Pharmaceuticals, Inc. | Chairman & COO | Current |
| Amphastar Pharmaceuticals, Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| China Healthcare Acquisition Corp. | Board of Directors | Current |
| The Hope Foundation | Board of Directors | Current |
| Amphastar Pharmaceuticals, Inc. | Board of Directors | Current |
| Redchip Companies, Inc. | Director | Current |
| Advancing Native Missions | Board of Directors | Current |
| Oral Roberts University | M.B.A. | Former |
| Colgate University | B.A. In Liberal Arts | Former |
Industry Transcripts by Seeking Alpha
-
Deere & Company F4Q09 (Qtr End 10/31/09) Earnings Call Transcript
on Nov 25, 2009about DE
-
Brown Shoe Co. Inc. Q3 2009 Earnings Call Transcript
on Nov 24, 2009about BWS
-
Daktronics Inc. F2Q10 (Qtr End 31/10/09) Earnings Call Transcript
on Nov 24, 2009about DAKT
-
Haynes International Inc. F4Q09 (Qtr End 09/30/09) Earnings Call Transcript
on Nov 24, 2009about HAYN
-
Valspar Corp. F4Q09 (Qtr End 30/10/09) Earnings Call Transcript
on Nov 23, 2009about VAL


